Page last updated: 2024-08-23

haloperidol decanoate and Dyskinesia, Drug-Induced

haloperidol decanoate has been researched along with Dyskinesia, Drug-Induced in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19905 (26.32)18.7374
1990's6 (31.58)18.2507
2000's6 (31.58)29.6817
2010's2 (10.53)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busanello, A; de Freitas, CM; de Moraes Reis, E; Fachinetto, R; Ferreira, J; Figueira, FH; Leal, CQ; Mello, CF; Röpke, J; Villarinho, JG1
Barcelos, RC; Benvegnú, DM; Boufleur, N; Bürger, ME; Emanuelli, T; Müller, LG; Pase, C; Reckziegel, P1
Kapur, S; Nobrega, JN; Remington, G; Turrone, P1
Agrawal, SM; McCullumsmith, RE; Meador-Woodruff, JH; Stincic, TL1
Aamo, TO; Andreassen, OA; Beal, MF; Ferrante, RJ; Jørgensen, HA1
Buschman, HP; Hariz, M; Kölling, P; Lenders, MW; Steur, EN; Vergouwen, MD1
Kantrowitz, JT; Srihari, VH; Tek, C1
Mori, A1
Harada, T; Kashihara, K; Sato, M1
Jaffe, E; Reider, R; Sharif, Z; Trémeau, F1
Egan, MF; Hyde, TM; Kleinman, JE; Weinberger, DR; Wing, LL; Wyatt, RJ1
Baca, SM; Egan, MF; Hamid, EH; Hyde, TM1
Andrén, PE; Gunne, L; Klintenberg, R1
Eklund, K; Forsman, A1
Cookson, JC1
Johansson, P1
Annable, L; Campbell, W; Chouinard, G1
Knudsen, P1
Bollen, J; De Cuyper, H; van Praag, HM; Verstraeten, D1

Reviews

1 review(s) available for haloperidol decanoate and Dyskinesia, Drug-Induced

ArticleYear
[Recent advances in clinical psychopharmacology].
    Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1984, Volume: 4, Issue:3

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzamides; Carbamazepine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Kinetics; Lithium; Psychopharmacology; Schizophrenia

1984

Trials

3 trial(s) available for haloperidol decanoate and Dyskinesia, Drug-Induced

ArticleYear
Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
    Clinical neuropharmacology, 1991, Volume: 14 Suppl 2

    Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Radioimmunoassay; Recurrence; Schizophrenia

1991
Side effects during long-term treatment with depot antipsychotic medication.
    Clinical neuropharmacology, 1991, Volume: 14 Suppl 2

    Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Parkinson Disease, Secondary; Psychomotor Agitation; Recurrence; Schizophrenia

1991
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:4

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

1989

Other Studies

15 other study(ies) available for haloperidol decanoate and Dyskinesia, Drug-Induced

ArticleYear
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2014, Oct-03, Volume: 54

    Topics: Animals; Antipsychotic Agents; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Endocannabinoids; Haloperidol; Male; Mastication; Movement; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Treatment Outcome

2014
Effects of omega-3 essential fatty acids (omega-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter.
    Neurotoxicity research, 2010, Volume: 17, Issue:3

    Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Fatty Acids, Omega-3; Haloperidol; Male; Maze Learning; Memory Disorders; Movement Disorders; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Time Factors

2010
The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
    Psychopharmacology, 2003, Volume: 165, Issue:2

    Topics: Animals; Antipsychotic Agents; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior

2003
Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat.
    European journal of pharmacology, 2003, Sep-12, Volume: 477, Issue:2

    Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dyskinesia, Drug-Induced; Gene Expression; Haloperidol; In Situ Hybridization; Injections, Intramuscular; Male; Mastication; Olanzapine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; RNA, Messenger

2003
Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats.
    Neuroscience, 2003, Volume: 122, Issue:3

    Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Cell Count; Disease Models, Animal; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Mastication; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Time; Time Factors

2003
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia.
    Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:7

    Topics: Athetosis; Chorea; Clopenthixol; Delayed-Action Preparations; Dominance, Cerebral; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Follow-Up Studies; Globus Pallidus; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Neurologic Examination; Outcome Assessment, Health Care; Schizophrenia; Treatment Outcome

2005
Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5

    Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Remission Induction; Schizophrenia; Substance-Related Disorders

2007
[Neuroleptic-induced dopaminergic supersensitivity following intermittent and continuous haloperidol administrations in rats].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 1984, Volume: 86, Issue:10

    Topics: Animals; Dyskinesia, Drug-Induced; Haloperidol; Male; Rats; Receptors, Dopamine

1984
Clozapine in tardive Tourette syndrome.
    Biological psychiatry, 1995, Aug-01, Volume: 38, Issue:3

    Topics: Adult; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Injections, Intramuscular; Male; Neurologic Examination; Schizophrenia; Schizophrenic Psychology; Social Behavior; Substance Withdrawal Syndrome; Tourette Syndrome

1995
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
    Psychopharmacology, 1995, Volume: 118, Issue:2

    Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley

1995
Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
    Brain research, 1998, Jun-15, Volume: 796, Issue:1-2

    Topics: Animals; Antipsychotic Agents; Corpus Striatum; Dizocilpine Maleate; Down-Regulation; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Haloperidol; Male; Mastication; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission

1998
Tardive dyskinesia model in the common marmoset.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:2

    Topics: Animals; Biperiden; Callithrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Female; Haloperidol; Male; Neurologic Examination; Parkinsonian Disorders

2002
Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats.
    Psychopharmacology, 1990, Volume: 100, Issue:1

    Topics: Animals; Azo Compounds; Behavior, Animal; Brain Diseases; Corpus Striatum; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Glutamate Decarboxylase; Haloperidol; Methylazoxymethanol Acetate; Pregnancy; Rats; Substantia Nigra

1990
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
    Acta psychiatrica Scandinavica. Supplementum, 1985, Volume: 322

    Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines

1985
Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration.
    The British journal of psychiatry : the journal of mental science, 1986, Volume: 148

    Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Kinetics; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders

1986